Published February 2018 | Version v1
Journal article

Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus–Positive Patients With Anal Cancer

  • 1. Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla (United States)
  • 2. Center for Translational Radiation Medicine and Imaging, University of California, San Diego, La Jolla (United States)
  • 3. Department of Gastroenterology, University of California, San Diego, La Jolla (United States)
  • 4. Clinical and Translational Research Institute, University of California, San Diego, La Jolla (United States)

Description

To study the effects of immunosuppression on treatment toxicity, long-term cancer recurrence risk, and survival among human immunodeficiency virus (HIV)-positive anal cancer patients.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2017.09.034

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2017.09.034;
PII
S0360301617339342;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
100
Journal Issue
2
Journal Page Range
p. 478-485
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54107066
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
AIDS VIRUS; IMMUNOSUPPRESSION; NEOPLASMS; PATIENTS; TOXICITY
Descriptors DEC
DISEASES; MICROORGANISMS; PARASITES; VIRUSES

Optional Information

Copyright
Copyright (c) 2017 Elsevier Inc. All rights reserved.